Impact of low frequency transcutaneous electrical nerve stimulation on symptomatic diabetic neuropathy using the new Salutaris® device

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 17, Issue 3, 2004, Pages 163-168

  Forst, Thomas ^a   Nguyen, M ^a   Forst, S ^a   Disselhoff, B ^b   Pohlmann, T ^a   Pfutzner A ^a  

^a IKFE GmbH   (Germany)

^b Pierenkemper GmbH   (Germany)

Author keywords

Diabetes mellitus; Diabetic neuropathy; Neuropathic pain; Transcutaneous electrical nerve stimulation

Indexed keywords

PLACEBO;

ADULT; AGED; ALLODYNIA; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; ELECTRICAL EQUIPMENT; ELECTROANALGESIA; ELECTRODE; ELECTROSTIMULATION THERAPY; FEMALE; HUMAN; LEG BLOOD FLOW; MALE; PAIN ASSESSMENT; PAIN THRESHOLD; PARESTHESIA; PERCEPTIVE THRESHOLD; PERONEUS NERVE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SENSORY NERVE; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TEMPERATURE SENSE; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT PLANNING; VIBRATION SENSE; VISUAL ANALOG SCALE;

AGED; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PERONEAL NERVE; PLACEBOS; QUESTIONNAIRES; TIME FACTORS; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION;

EID: 4344633085     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Boulton A.J., Ward J.D.: Diabetic neuropathies and pain. Clin. Endocrinol. Metab. 15: 917-931, 1986.
2. Boulton A.J., Knight G., Drury J., Ward J.D.: The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population. Diabetes Care 8: 125-128, 1985.
3. Pfeifer M.A., Ross D.R., Schrage J.P., Gelber D.A., Schumer M.P., Crain G.M., Markwell S.J., Jung S.: A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy. Diabetes Care 16: 1103-1115, 1993.
4. Armstrong D., Lavery L.A., Fleischli J.G., Gilham K.A.: Is electrical stimulation effective in reducing neuropathic pain in patients with diabetes. J. Foot Ankle Surg. 36: 260-263, 1997.
5. Kumar D., Marshall H.J.: Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation. Diabetes Care 20: 1702-1705, 1997.
6. Forst T., Pfützner A., Ayric H., Ambrosch A., Lehnert H., Küstner E.: Die transkutane elektrische Nervenstimulation in der Therapie der symptomatischen diabetischen Polyneuropathie. Diabetes und Stoffwechsel 5: 203-208, 1996.
7. Monafo W.W., Eliasson S.G., Shimazaki S., Sugimoto H.: Regional blood flow in resting and stimulated sciatic nerve of diabetic rats. Exp. Neurol. 99: 607-614, 1988.
8. Cameron N.E., Cotter M.A., Robertson S.: Chronic low frequency electrical activation for one week corrects nerve conduction velocity deficits in rats with diabetes of three months duration. Diabetologia 32: 759-761, 1989.
9. Cameron N.E., Cotter M.A., Robertson S., Maxfield E.K.: Nerve function in experimental diabetes in rats: effects of electrical stimulation. Am. J. Physiol. 264: E161-E166, 1993.
10. Walsh D.M., Foster N.E., Baxter G.D., Allen J.M.: Transcutaneous electrical nerve stimulation. Relevance of stimulation parameters to neurophysiological and hypoalgesic effects. Am. J. Phys. Med Rehabil. 74:199-206, 1995.
11. Ashton H., Golding J.F., Marsh V.R., Thompson J.W.: Effects of transcutaneous electrical nerve stimulation and aspirin on late somatosensory evoked potentials in normal subjects. Pain 18: 377-386, 1984.
12. Forst T., Pfützner A., Bauersachs R., Arin M., Bach B., Biehlmaier H., Kustner E., Beyer J.: Comparison of the microvascular response to transcutaneous electrical nerve stimulation and postocclusive ischemia in the diabetic foot. J. Diabetes Complications 11: 291-297, 1997.
13. Baker L.L., Chambers R., DeMuth S.K., Villar F.: Effects of electrical stimulation on wound healing in patients with diabetic ulcers. Diabetes Care 20: 405-412, 1997.
14. Kloth L.C., Feedar J.A.: Acceleration of wound healing with high voltage, monophasic, pulsed current. J. Am. Phys. Ther. 68: 503-508, 1988.
15. Ziegler D., Hanefeld M., Ruhnau K.J., Hasche H., Lobisch M., Schutte K., Kerum G., Malessa R.: Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 22: 1296-1301, 1999.
16. Bastyr E.J., Zhang D.: Neuropathy Total Symptom Score-6 (NTSS-6) questionnaire: a reliable measure of symptoms indicating changes in diabetic peripheral neuropathy (DPN). Diabetologia 45 (Suppl.2), A331, 2002.
17. Ziegler D., Hanefeld M., Ruhnau K. J., Meissner H.P., Lobisch M., Schutte K., Gries F.A.: The ALADIN Study group: Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid: a 3 weeks randomized controlled trial (ALADIN Study). Diabetologia 38:1425-1433, 1995.
18. Sriwatanakul K., Kelvie W., Lasagna L., Calimlim J.F., Weis O.F., Mehta G.: Studies with different types of visual analog scales for measurement of pain. Clin. Pharmacol. Ther. 34: 234-239, 1983.
19. Scott J., Huskisson E.C.: Graphic representation of pain. Pain 2: 175-184, 1976.
20. Claus D., Mustafa C., Vogel W., Herz M., Neundorfer B.: Assessment of diabetic neuropathy: definition of norm and discrimination of abnormal nerve function. Muscle Nerve 16: 757-768, 1993.
21. Pfützner A., Kunt T., Löbig M., Pohlmann T., Goitom K., Magin T., Engelbach M., Beyer J., Forst T.: Small nerve fibre function, neurovascular control and substance P in diabetes mellitus type 1. Diabetologia 42: A302, 1999.
22. Forst T., Kunt T., Pohlmann T., Goitom K., Löbig M., Engelbach M., Beyer J., Pfützner A.: Microvascular skin blood flow following the ingestion of 75g Glucose in healthy individuals. Exp. Clin. Endocrinol. Diabetes 106: 453-458, 1998.
23. Franzeck U.K., Stengele B., Panradl U., Wahl P., Tillmanns H.: Cutaneous reactive hyperaemia in short term and long term type 1 diabetes - continuous monitoring by a combined laser doppler and transcutaneous oxygen probe. Vasa 19: 8-15, 1990.
24. Forst T., Pohlmann T., Kunt T., Goitom K., Schulz G., Lobig M., Engelbach M., Beyer J., Pfutzner A.: The influence of local capsaicin treatment on small nerve fibre function and neurovascular control in symptomatic diabetic neuropathy. Acta Diabetol. 39: 1-6, 2002.
25. Benbow S.J., Cossins L., MacFarlane I.A.: Painful diabetic neuropathy. Diabet. Med. 16: 632-644, 1999.
26. Morley G.K., Mooradian A.D., Levine A.S., Morley J. E.: Mechanism of pain in diabetic peripheral neuropathy. Effect of glucose on pain perception in humans. Am. J. Med. 77: 79-82, 1984.
27. Alvaro M., Kumar D., Julka I.S.: Transcutaneous electrostimulation: emerging treatment for diabetic neuropathic pain. Diabetes Technol. Ther. 1: 77-80, 1999.
28. Pomeranz B., Paley D.: Electroacupuncture hypalgesia is mediated by afferent nerve impulses: an electrophysiological study in mice. Exp. Neurol. 66: 398-402, 1979.
29. Sjolund B., Terenius L., Eriksson M.: Increased cerebrospinal fluid levels of endorphins after electro-acupuncture. Acta Physiol Scand. 100: 382-384, 1977.
30. Sjolund B.H., Eriksson M.B.: The influence of naloxone on analgesia produced by peripheral conditioning stimulation. Brain Res. 173: 295-301, 1979.
31. Watkins E.S., Koeze T.H.: Spinal cord stimulation and pain relief. BMJ 307: 462, 1993.
32. Han J.S., Chen X.H., Sun S.L., Xu X.J., Yuan Y., Yan S.C., Hao J.X., Terenius L.: Effect of low- and high-frequency TENS on Met-enkephalin-Arg-Phe and dynorphin A immunoreactivity in human lumbar CSF. Pain 47: 295-298, 1991.